These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Lack of effect of erythromycin and ketoconazole on the pharmacokinetics and pharmacodynamics of steady-state intranasal levocabastine. Pesco-Koplowitz L; Hassell A; Lee P; Zhou H; Hall N; Wiesinger B; Mechlinski W; Grover M; Hunt T; Smith R; Travers S J Clin Pharmacol; 1999 Jan; 39(1):76-85. PubMed ID: 9987703 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and safety of ebastine in healthy subjects and patients with renal impairment. Noveck RJ; Preston RA; Swan SK Clin Pharmacokinet; 2007; 46(6):525-34. PubMed ID: 17518511 [TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetic properties of topical levocabastine. A review. Heykants J; Van Peer A; Van de Velde V; Snoeck E; Meuldermans W; Woestenborghs R Clin Pharmacokinet; 1995 Oct; 29(4):221-30. PubMed ID: 8549024 [TBL] [Abstract][Full Text] [Related]
7. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis. De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of loratadine in patients with renal insufficiency. Matzke GR; Halstenson CE; Opsahl JA; Hilbert J; Perentesis G; Radwanski E; Zampaglione N J Clin Pharmacol; 1990 Apr; 30(4):364-71. PubMed ID: 2140371 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of emedastine difumarate, a new anti-histaminic agent in patients with renal impairment. Joukhadar C; Herranz U; Pernerstorfer T; Assandri A; Klein N; Schrolnberger C; Lackner E; Eichler HG; Müller M Eur J Clin Pharmacol; 2001 Mar; 56(12):905-10. PubMed ID: 11317479 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of cefadroxil in normal subjects and in patients with renal insufficiency. Humbert G; Leroy A; Fillastre JP; Godin M Chemotherapy; 1979; 25(4):189-95. PubMed ID: 456077 [TBL] [Abstract][Full Text] [Related]
11. Effect of severe renal failure and haemodialysis on the pharmacokinetics of levosimendan and its metabolites. Puttonen J; Kantele S; Kivikko M; Häkkinen S; Harjola VP; Koskinen P; Pentikäinen PJ Clin Pharmacokinet; 2007; 46(3):235-46. PubMed ID: 17328582 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and safety of ebastine in patients with impaired hepatic function compared with healthy volunteers: a phase I open-label study. Lasseter KC; Dilzer SC; Vargas R; Waldman S; Noveck RJ Clin Pharmacokinet; 2004; 43(2):121-9. PubMed ID: 14748620 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of ceftazidime in patients with renal insufficiency and in those undergoing hemodialysis. Ohkawa M; Nakashima T; Shoda R; Ikeda A; Orito M; Sawaki M; Sugata T; Shimamura M; Hirano S; Okumura K Chemotherapy; 1985; 31(6):410-6. PubMed ID: 3908006 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of cefepime in subjects with renal insufficiency. Barbhaiya RH; Knupp CA; Forgue ST; Matzke GR; Guay DR; Pittman KA Clin Pharmacol Ther; 1990 Sep; 48(3):268-76. PubMed ID: 2401125 [TBL] [Abstract][Full Text] [Related]
16. Metabolism of flecainide. Conard GJ; Ober RE Am J Cardiol; 1984 Feb; 53(5):41B-51B. PubMed ID: 6364769 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic study of an oral cephalosporin, cefdinir, in hemodialysis patients. Hishida A; Ohishi K; Nagashima S; Kanamaru M; Obara M; Kitada A Antimicrob Agents Chemother; 1998 Jul; 42(7):1718-21. PubMed ID: 9661010 [TBL] [Abstract][Full Text] [Related]
18. Influence of the hemodialysis on the half-life of practolol in patients with severe renal failure. Harvengt C; Desager JP; Muschart JM; Tjandramaga YB; Verbeeck R; Verberckmoes R J Clin Pharmacol; 1975; 15(8-9):605-10. PubMed ID: 1167308 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of oral talinolol following a single dose and during steady state in patients with chronic renal failure and healthy volunteers. Krueger M; Achenbach H; Terhaag B; Haase H; Richter K; Oertel R; Preiss R Int J Clin Pharmacol Ther; 2001 Feb; 39(2):61-6. PubMed ID: 11270803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]